2004
DOI: 10.1007/s11916-004-0057-1
|View full text |Cite
|
Sign up to set email alerts
|

Menstrual migraine: A review of prophylactic therapies

Abstract: Menstrual migraine is commonly encountered in women who are experiencing attacks of migraine without aura. It remains controversial whether attacks of menstrually associated migraine are more severe and have a longer duration than non-menstrually associated attacks. The pathogenesis of menstrual migraine is not understood completely, but it may be related to estrogen withdrawal or prostaglandin release. Preventative therapies may be considered in those who have failed abortive medications or have attacks lasti… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
21
0

Year Published

2005
2005
2014
2014

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 30 publications
(21 citation statements)
references
References 60 publications
0
21
0
Order By: Relevance
“…More recent studies using estradiol gel (1.5 mg) 2 to 7 days before menses have demonstrated improvement in MM [33], and Pringsheim and colleagues [15••] recommended that it be used routinely. Martin [34] notes that there is little evidence to support use of 50-μg transdermal estradiol patches; however, doses of 100 μg have been suggested as necessary for success in treating MM. Evidence that they improve MM is fair, and their benefi t outweighs the risk.…”
Section: Hormonal Therapiesmentioning
confidence: 99%
See 1 more Smart Citation
“…More recent studies using estradiol gel (1.5 mg) 2 to 7 days before menses have demonstrated improvement in MM [33], and Pringsheim and colleagues [15••] recommended that it be used routinely. Martin [34] notes that there is little evidence to support use of 50-μg transdermal estradiol patches; however, doses of 100 μg have been suggested as necessary for success in treating MM. Evidence that they improve MM is fair, and their benefi t outweighs the risk.…”
Section: Hormonal Therapiesmentioning
confidence: 99%
“…These include tamoxifen, phytoestrogens, danazol, gonadotropin-releasing hormone, and bromocriptine [34]. These agents are best reserved for women who are refractory to the mainstream approaches to MM.…”
Section: Hormonal Therapiesmentioning
confidence: 99%
“…Consequently, the cyclic fluctuations in these hormones cause cyclic changes in other body systems as well. Underlying medical conditions that are often aggravated with the onset of menstruation include epilepsy, 32,33 chronic pelvic pain, 34,35 migraine headache, [36][37][38][39][40] and mood disturbances. 41,42 More recently, exacerbations of asthma have been linked to menstruation.…”
Section: Other Menstrual-associated Disordersmentioning
confidence: 99%
“…In some patients, despite a low frequency of headaches, a severely disabling MM may require preventative therapy [14].…”
Section: Treatment Of MMmentioning
confidence: 99%